Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, pitavastatin (Livazo®) cannot be endorsed for use within NHS Wales for the treatment of hypercholesterolaemia and dyslipidaemia. |
||
|
||
Medicine details |
||
| Medicine name | pitavastatin (Livazo®) | |
| Formulation | film-coated tablet | |
| Reference number | 457 | |
| Indication | For the treatment of hypercholesterolaemia and dyslipidaemia. |
|
| Company | Kowa Pharmaceutical Europe Co Ltd | |
| BNF chapter | Cardiovascular system | |
| Submission type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Ratification by Welsh Government | Not available | |
| Date of issue | 18/10/2010 | |